Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC117

Naloxegól eða lyfjafræðilega hæft salt þar af

  • Status:
    Veitt
  • Application date:
    4.5.2015
  • Application published:
    15.6.2015
  • Grant published:
    15.11.2016
  • Max expiry date:
    9.12.2029
  • Next due date:
    31.12.2026
  • Medicine name:
    Moventig
  • Medicine for children:
    No

Timeline

Today
4.5.2015Application
15.6.2015Publication
15.11.2016Registration
15.12.2026Expires

Marketing license

  • IS authorization number:
    EU/1/14/962-001-003; EU/1/14/962-004-007
  • Date:
    20.12.2014
  • Foreign authorization number:
    EU/1/14/962
  • Date:
    8.12.2014

Owner

  • Name:
    Nektar Therapeutics
  • Address:
    455 Mission Bay Boulevard South Suite 100, San Francisco US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 5.11.2024

Expires: 15.12.2025

Payer: Árnason Faktor ehf.

Number: 2

Paid: 15.12.2025

Expires: 15.12.2026

Payer: Árnason Faktor ehf.

Upload documents